This is an extended learning activity. Read the longer CPD article here.

Learning objectives

After successful completion of this CPD activity, pharmacists should be able to:

  • Discuss comorbidity considerations that need to be made when choosing antiretroviral therapy for HIV
  • Describe key factors for consideration when switching antiretroviral therapy
  • Explain the pharmacist’s role in supporting people living with HIV who also have comorbidities or coinfections.

Competency (2016) Standards addressed:  1.1, 1.4, 1.5, 2.2, 3.1, 3.5

Already read the extended learning activity in the journal? Scroll to the bottom to SUBMIT ANSWERS.

This extended learning activity is designed to extend the learner and incorporate additional reading and research by the learner. Further reading and research is required from:

  • Therapeutic Guidelines 
  • AMH
  • Stockley’s Drug Interactions
  • Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) Antiretroviral Guidelines (https://arv.ashm.org.au/) 
  • Guidelines for the Use of Antiretroviral Agent

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.

CPD LOGIN
Click here to become a member

RELATED ARTICLESMORE FROM AUTHOR